Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Angiostatin inhibits experimental liver fibrosis in mice.

Vogten JM, Drixler TA, te Velde EA, Schipper ME, van Vroonhoven TJ, Voest EE, Borel Rinkes IH.

Int J Colorectal Dis. 2004 Jul;19(4):387-94. Epub 2004 Jan 10.

PMID:
14716496
2.

Plasminogen mediates liver regeneration and angiogenesis after experimental partial hepatectomy.

Drixler TA, Vogten JM, Gebbink MF, Carmeliet P, Voest EE, Borel Rinkes IH.

Br J Surg. 2003 Nov;90(11):1384-90.

PMID:
14598419
3.

Angiostatin prolongs the survival of mice with leptomeningeal metastases.

Reijneveld JC, Taphoorn MJ, Kerckhaert OA, Drixler TA, Boogerd W, Voest EE.

Eur J Clin Invest. 2003 Jan;33(1):76-81.

PMID:
12492456
4.

Liver regeneration is an angiogenesis- associated phenomenon.

Drixler TA, Vogten MJ, Ritchie ED, van Vroonhoven TJ, Gebbink MF, Voest EE, Borel Rinkes IH.

Ann Surg. 2002 Dec;236(6):703-11; discussion 711-2.

5.

Angiostatin inhibits pathological but not physiological retinal angiogenesis.

Drixler TA, Borel Rinkes IH, Ritchie ED, Treffers FW, van Vroonhoven TJ, Gebbink MF, Voest EE.

Invest Ophthalmol Vis Sci. 2001 Dec;42(13):3325-30.

PMID:
11726640
6.

Angiogenesis and surgery: from mice to man.

Drixler TA, Voest EE, van Vroonhoven TJ, Borel Rinkes IH.

Eur J Surg. 2000 Jun;166(6):435-46. Review. No abstract available.

PMID:
10890539
7.

Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy.

Drixler TA, Borel Rinkes IH, Ritchie ED, van Vroonhoven TJ, Gebbink MF, Voest EE.

Cancer Res. 2000 Mar 15;60(6):1761-5.

8.

Implant failure four years after resection and reconstruction of a femur for a chondrosarcoma.

Broos PL, Drixler TA, Vogten T, De Wever I.

Acta Orthop Belg. 1996 Dec;62(4):244-8.

PMID:
9008970

Supplemental Content

Loading ...
Support Center